A phase II clinical trial of the vascular disrupting agent BNC105P as second line chemotherapy for advanced Malignant Pleural Mesothelioma
| Image |  |
|---|---|
| Description | scientific article published on 17 June 2013 |
| Author/s |
author: Anna K. Nowak Jenette Creaney Michael J. Boyer Chris Brown |
| Publication date | June 17, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |